Recent studies have demonstrated that detrimental alterations in mitochondrial complex I and IV genes, including MT-ND4 and MT-CO1, are linked to enhanced oxidative phosphorylation activity and increased aggressiveness in high-grade and treatment-resistant prostate cancers. Here, MT-CO1 is linked to prostate carcinoma.